Influence of NADPH oxidase on inflammatory response in primary intestinal epithelial cells in patients with ulcerative colitis

BMC Gastroenterology

Volumn 13, Issue 1, 2013, Pages

  Ramonaite, Rima ^a   Skieceviciene, Jurgita ^a   Kiudelis, Gediminas ^a   Jonaitis, Laimas ^a   Tamelis, Algimantas ^a   Cizas, Paulius ^a   Borutaite, Vilmante ^a   Kupcinskas, Limas ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Cell biology; Cytokines; NADPH oxidase; Ulcerative colitis

Indexed keywords

APOCYNIN; CYTOKINE; ENZYME INHIBITOR; HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CELL VIABILITY; CHELATION; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; FLUORESCENCE MICROSCOPY; FLUOROMETRY; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE EPITHELIUM CELL; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; CELL SURVIVAL; CELLS, CULTURED; COLITIS, ULCERATIVE; COLON; ENZYME INHIBITORS; EPITHELIAL CELLS; FEMALE; HUMANS; HYDROGEN PEROXIDE; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NADPH OXIDASE; ONIUM COMPOUNDS; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84887354149     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-13-159     Document Type: Article

References (33)

1. Iwamoto M, Koji T, Makiyama K. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol 1996, 180(2):152-159. 10.1002/(SICI)1096-9896(199610)180:2<152::AID-PATH649>3.0.CO;2-Y, 8976873.
2. Siggers RH, Hackam DJ. The role of innate immune-stimulated epithelial apoptosis during gastrointestinal inflammatory diseases. Cell Mol Life Sci 2011, 68(22):3623-3634. 10.1007/s00018-011-0821-4, 21986983.
3. Cooney R, Jewell D. The genetic basis of inflammatory bowel disease. Digest Dis 2009, 27:428-442.
4. McKenzie SJ, Baker MS, Buffinton GD, Doe WF. Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 1996, 98(1):136-141. 10.1172/JCI118757, 507409, 8690784.
5. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87(1):245-313. 10.1152/physrev.00044.2005, 17237347.
6. Kawahara T, Kuwano Y, Teshima-Kondo S, Takeya R, Sumimoto H, Kishi K, Tsunawaki S, Hirayama T, Rokutan K. Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to Toll-like receptor 5 signaling in large intestinal epithelial cells. J Immunol 2004, 172(5):3051-3058.
7. Park HS, Jung HY, Park EY, Kim J, Lee WJ, Bae YS. Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol 2004, 173(6):3589-3593.
8. El-Benna J, Dang PM, Gougerot-Pocidalo MA. Role of the NADPH oxidase systems Nox and Duox in host defense and inflammation. Expert Rev Clin Immunol 2007, 3(2):111-115. 10.1586/1744666X.3.2.111, 20477098.
9. Davies GR, Simmonds NJ, Stevens TR, Grandison A, Blake DR, Rampton DS. Mucosal reactive oxygen metabolite production in duodenal ulcer disease. Gut 1992, 33(11):1467-1472. 10.1136/gut.33.11.1467, 1379529, 1452069.
10. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, Shugart YY, Griffiths AM, Targan SR, Ippoliti AF, Bernard EJ, Mei L, Nicolae DL, Regueiro M, Schumm LP, Steinhart AH, Rotter JI, Duerr RH, Cho JH, Daly MJ, Brant SR. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007, 39(5):596-604. 10.1038/ng2032, 2757939, 17435756.
11. Muise AM, Xu W, Guo CH, Walters TD, Wolters VM, Fattouh R, Lam GY, Hu P, Murchie R, Sherlock M, Gana JC NEOPICS, Russell RK, Glogauer M, Duerr RH, Cho JH, Lees CW, Satsangi J, Wilson DC, Paterson AD, Griffiths AM, Silverberg MS, Brumell JH. NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2. Gut 2012, 61(7):1028-1035. 10.1136/gutjnl-2011-300078, 3806486, 21900546.
12. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991, 325(13):928-937. 10.1056/NEJM199109263251306, 1881418.
13. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987, 317:1625-1629. 10.1056/NEJM198712243172603, 3317057.
14. Riley SA, Mani V, Goodman MJ, Dutt S, Herd ME. Microscopic activity in ulcerative colitis: what does it mean?. Gut 1991, 32(2):174-178. 10.1136/gut.32.2.174, 1378803, 1864537.
15. Seidelin JB, Horn T, Nielsen OH. Simple and efficient method for isolation and cultivation of endoscopically obtained human colonocytes. Physiol Gastrointest Liver Physiol 2003, 285(6):G1122-G1128.
16. Babior BM. NADPH oxidase. Curr Opin Immunol 2004, 16(1):42-47.
17. Heumüller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schröder K, Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 2008, 51(2):211-217. 10.1161/HYPERTENSIONAHA.107.100214, 18086956.
18. Szanto I, Rubbia-Brandt L, Kiss P, Steger K, Banfi B, Kovari E, Herrmann F, Hadengue A, Krause KH. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 2005, 207(2):164-176. 10.1002/path.1824, 16086438.
19. Stefanska J, Pawliczak R. Apocynin: molecular aptitudes. Mediators Inflamm 2008, 106:507. doi:10.1155/2008/106507.
20. Choi EM, Lee YS. Protective effect of apocynin on antimycin A-induced cell damage in osteoblastic MC3T3-E1 cells. J Appl Toxicol 2012, 32(9):714-721. 10.1002/jat.1689, 21538410.
21. Palmen MJHJ, Beukelman CJ, Mooij RGM, Pena AS, Van-Rees EP. Anti-inflammatory effect of apocynin, a plant-derived NADPH oxidase antagonist, in acute experimental colitis. Netherl J Med 1995, 47(2):A41-A41.
22. Masuda H, Iwai S, Tanaka T, Hayakawa S. Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase. J Clin Lab Immunol 1995, 46:111-123.
23. Olsen T, Goll R, Cui G, Husebekk A, Vonen B, Birketvedt GS, Florholmen J. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis. Scand J Gastroenterol 2007, 42(11):1312-1320. 10.1080/00365520701409035, 17852866.
24. Sareila O, Kelkka T, Pizzolla A, Hultqvist M, Holmdahl R. NOX2 complex-derived ROS as immune regulators. Antioxid Redox Signal 2011, 15(8):2197-2208. 10.1089/ars.2010.3635, 20919938.
25. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011, 474(7351):298-306. 10.1038/nature10208, 21677746.
26. Marin M, Giner RM, Rios JL, Recio Mdel C. Protective effect of apocynin in a mouse model of chemically-induced colitis. Planta Med 2013, 79(15):1392-1400.
27. Hershberg RM. The epithelial cell cytoskeleton and intracellular trafficking. V. Polarized compartmentalization of antigen processing and Toll-like receptor signaling in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2002, 283(4):G833-G839.
28. Van den Worm E, Beukelman CJ, Van den Berg AJ, Kroes BH, Labadie RP, Van Dijk H. Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. Eur J Pharmacol 2001, 433(2-3):225-230.
29. Impellizzeri D, Esposito E, Mazzon E, Paterniti I, Di Paola R, Bramanti P, Cuzzocrea S. Effect of apocynin, a NADPH oxidase inhibitor, on acute lung inflammation. Biochem Pharmacol 2011, 81(5):636-648. 10.1016/j.bcp.2010.12.006, 21147071.
30. Wu F, Tyml K, Wilson JX. iNOS expression requires NADPH oxidase-dependent redox signaling in microvascular endothelial cells. J Cell Physiol 2008, 217:207-214. 10.1002/jcp.21495, 2551742, 18481258.
31. Rokutan K, Kawahara T, Kuwano Y, Tominaga K, Nishida K, Teshima-Kondo S. Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal tract. Semin Immunopathol 2008, 3:315-327.
32. Rada B, Leto TL. Oxidative innate immune defenses by Nox/Duox family NADPH Oxidases. Contrib Microbiol 2008, 15:164-187. 2776633, 18511861.
33. Geiszt M, Leto TL. The Nox Family of NAD (P) H Oxidases: host defense and beyond. J Biol Chem 2004, 279(50):51715-51718. 10.1074/jbc.R400024200, 15364933.